Brief: India's Zim Laboratories June Qtr PAT falls
06/08/2019 13:39
Aug 6 (Reuters) - Zim Laboratories Ltd ZIML.BO :
* JUNE QUARTER CONSOL PAT 865,000 RUPEES VERSUS 37.9 MILLION
RUPEES YEAR AGO
* JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 674.1 MILLION
RUPEES
VERSUS 710.5 MILLION RUPEES YEAR AGO
Source text : [https://bit.ly/2MLlm4b]
Further company coverage: ZIML.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zim Laboratories
See all newsBrief: Zim Laboratories Gets Marketing Authorization For Dabigatran Etexilate Capsules In Italy, Europe
Brief: Zim Laboratories March-Quarter Consol Net Profit 37.4 Mln Rupees
Brief: Zim Laboratories To Consider Fund Raising Via Securities Issuance
Brief: Zim Laboratories Gets Marketing Authorization For Tamsulosin + Dutasteride Capsules In Australia
India's Zim Laboratories up after getting marketing authorization for migraine drug in Australia